Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Creation of a Biological Drug Delivery System

EF 2013-14

Résumé
Current estimates postulate that a quarter of Canadian are afflicted by diabetes. But with the increasing age of the Canadian population and the poor diet of many Canadians, the number of Canadians with this disease may increase further. Though diabetes is a manageable disease, it may lead to vision loss, loss of sensation and even amputation. Additionally, diabetes is often accompanied by other diseases. Many diabetics develop or have already developed some degree of cardiovascular disease or kidney disease, putting them at risk of strokes or heart attacks. Though diabetes was first discovered in ancient Egypt about 3000 years ago, a practical solution to treating this disease has yet to be discovered. Physicians typically suggest that diabetics adhere to a strict diet and exercise plan in addition to regularly taking oral medications. Unfortunately, these medications cannot manage diabetes in the long term, failing to keep pace with development of the disease. Eventually the disease progresses to a state where the only non-invasive mode of therapy is daily injections of insulin. Insulin therapy is capable of managing diabetes so that a patient lives a long and enjoyable life but many patients struggle to properly adhere to ideal insulin therapy. This is likely because insulin therapy is complex, requiring a patient to closely monitor their blood sugars, carbohydrate and protein intake and insulin shots. Moreover, such therapy requires patients to check their blood sugars at least once daily (potentially four times daily) and inject insulin in to their abdomens several times a day. With such a complex and inconvenient treatment plan, a new and improved method of insulin delivery is required. The ideal system would be require minimal maintenance, be comfortable to use and release insulin only when required. Fortunately, much work has been already conducted to develop such a system. Insulin secreting cells have been combined with gel like materials to form a cell-gel mixture. This combination has been implanted in to the abdomen of mice so that insulin is released in to their blood. In addition, release of insulin from this system may be turned on and off with light, providing some control over insulin release. However, further studies must be conducted to answer the many questions surrounding the safety, efficacy and practicality of this system as a suitable alternative for diabetes treatment. First, the relationship between light signals, the amount of insulin released and change in blood sugars must be investigated. The long term effects of an implant on the body must also be investigated. In particular, the long term effect of this system on blood sugar control and diabetes would need to be evaluated prior to conducting additional research. Hence, this project aims to characterize this system's properties and to investigate the prudence of this system as an additional tool to treat diabetes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
311857
Name
Chen Christopher B
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Creation of a Biological Drug Delivery System
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomedical Engineering; Diabetes; Drug Delivery
Abstract
Current estimates postulate that a quarter of Canadian are afflicted by diabetes. But with the increasing age of the Canadian population and the poor diet of many Canadians, the number of Canadians with this disease may increase further. Though diabetes is a manageable disease, it may lead to vision loss, loss of sensation and even amputation. Additionally, diabetes is often accompanied by other diseases. Many diabetics develop or have already developed some degree of cardiovascular disease or kidney disease, putting them at risk of strokes or heart attacks. Though diabetes was first discovered in ancient Egypt about 3000 years ago, a practical solution to treating this disease has yet to be discovered. Physicians typically suggest that diabetics adhere to a strict diet and exercise plan in addition to regularly taking oral medications. Unfortunately, these medications cannot manage diabetes in the long term, failing to keep pace with development of the disease. Eventually the disease progresses to a state where the only non-invasive mode of therapy is daily injections of insulin. Insulin therapy is capable of managing diabetes so that a patient lives a long and enjoyable life but many patients struggle to properly adhere to ideal insulin therapy. This is likely because insulin therapy is complex, requiring a patient to closely monitor their blood sugars, carbohydrate and protein intake and insulin shots. Moreover, such therapy requires patients to check their blood sugars at least once daily (potentially four times daily) and inject insulin in to their abdomens several times a day. With such a complex and inconvenient treatment plan, a new and improved method of insulin delivery is required. The ideal system would be require minimal maintenance, be comfortable to use and release insulin only when required. Fortunately, much work has been already conducted to develop such a system. Insulin secreting cells have been combined with gel like materials to form a cell-gel mixture. This combination has been implanted in to the abdomen of mice so that insulin is released in to their blood. In addition, release of insulin from this system may be turned on and off with light, providing some control over insulin release. However, further studies must be conducted to answer the many questions surrounding the safety, efficacy and practicality of this system as a suitable alternative for diabetes treatment. First, the relationship between light signals, the amount of insulin released and change in blood sugars must be investigated. The long term effects of an implant on the body must also be investigated. In particular, the long term effect of this system on blood sugar control and diabetes would need to be evaluated prior to conducting additional research. Hence, this project aims to characterize this system's properties and to investigate the prudence of this system as an additional tool to treat diabetes.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chen, Christopher B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~